HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olivier Gaide Selected Research

Ectodysplasins

2/2014Generation and characterization of function-blocking anti-ectodysplasin A (EDA) monoclonal antibodies that induce ectodermal dysplasia.
9/2009Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X-linked ectodermal dysplasia.
11/2007Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia.
10/2004Ectodysplasin A1 promotes placodal cell fate during early morphogenesis of ectodermal appendages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olivier Gaide Research Topics

Disease

9Neoplasms (Cancer)
03/2021 - 05/2008
5Ectodermal Dysplasia (Aplasia Cutis Congenita)
02/2014 - 11/2007
4Contact Dermatitis (Eczema, Contact)
01/2017 - 08/2007
3Melanoma (Melanoma, Malignant)
01/2021 - 10/2014
3Skin Neoplasms (Skin Cancer)
01/2021 - 10/2007
3Infections
01/2012 - 11/2007
3Anhidrotic Ectodermal Dysplasia 1
10/2009 - 11/2007
2Basal Cell Carcinoma (Rodent Ulcer)
01/2021 - 11/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 10/2014
2Stevens-Johnson Syndrome (Lyell's Syndrome)
02/2013 - 10/2007
1Lymphoma (Lymphomas)
01/2022
1Neoplasm Metastasis (Metastasis)
03/2021
1Dermatofibrosarcoma
04/2020
1Sarcoma (Soft Tissue Sarcoma)
04/2020
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
03/2016
1Mycosis Fungoides
03/2016
1Actinic Keratosis
01/2016
1Inflammation (Inflammations)
01/2016
1Conjunctivitis
01/2016
1Bites and Stings (Sting)
12/2015
1Colonic Neoplasms (Colon Cancer)
12/2015
1Gastritis
12/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2014
1Keratoacanthoma
10/2014
1Burnett Schwartz Berberian syndrome
10/2014
1Fatigue
10/2014
1Pain (Aches)
04/2014
1Atopic Dermatitis (Atopic Eczema)
12/2013
1Asthma (Bronchial Asthma)
12/2013
1Hypotrichosis
09/2009
1Sezary Syndrome (Sezary Erythroderma)
05/2008
1Gout
01/2008
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2007
1Eczema
08/2007
1Necrosis
10/2004

Drug/Important Bio-Agent (IBA)

4EctodysplasinsIBA
02/2014 - 10/2004
3InflammasomesIBA
12/2013 - 08/2007
2AntibodiesIBA
02/2014 - 09/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 05/2008
2LigandsIBA
10/2009 - 05/2008
2Death Domain ReceptorsIBA
05/2008 - 10/2007
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2021
1IntegrinsIBA
11/2018
1Fibronectins (Fibronectin)IBA
11/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2018
1Collagen Type XVIIIBA
01/2018
1Interleukin-17 (Interleukin 17)IBA
01/2017
1DinitrofluorobenzeneIBA
01/2017
13-ingenyl angelateIBA
01/2016
1SteroidsIBA
01/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2016
1Fusidic Acid (Fucithalmic)IBA
01/2016
1cyclic guanosine monophosphate-adenosine monophosphateIBA
12/2015
1Adenosine Monophosphate (AMP)IBA
12/2015
1DNA (Deoxyribonucleic Acid)IBA
12/2015
1Immunoglobulin E (IgE)IBA
12/2014
1Immunoglobulin G (IgG)IBA
12/2014
1Pharmaceutical PreparationsIBA
12/2014
1Peptide Hydrolases (Proteases)FDA Link
12/2014
1Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA
12/2014
1VemurafenibIBA
10/2014
1trametinibIBA
10/2014
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2014
1Mitogen-Activated Protein KinasesIBA
10/2014
1dabrafenibIBA
10/2014
11-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2014
1Monoclonal AntibodiesIBA
02/2014
1Blocking AntibodiesIBA
02/2014
1CytokinesIBA
12/2013
1Interleukin-1 (Interleukin 1)IBA
12/2013
1Thymic Stromal LymphopoietinIBA
12/2013
1Biological ProductsIBA
08/2013
1TNF-Related Apoptosis-Inducing LigandIBA
03/2013
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2013
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2012
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2012
1Proteins (Proteins, Gene)FDA Link
09/2009
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
05/2008
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
05/2008
1chlorobenzeneIBA
08/2007
1Edar ReceptorIBA
10/2004

Therapy/Procedure

5Therapeutics
03/2016 - 09/2009
2Radiotherapy
01/2022 - 10/2019
2Immunotherapy
03/2021 - 12/2015
1Transplantation
01/2021
1Organ Transplantation
01/2021
1Operative Surgical Procedures
04/2020
1Immunomodulation
12/2014